EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM (Public limited company)

BVBA CHEMIPHAR
BE 0435.237.515 Active ●Lieven Bauwensstraat 6, 8200 Bruges

EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0435.237.515. It was founded on 09-09-1988. Its registered office is in Bruges. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 816 310 and a profit of € 103 882. These accounts report 20 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0435.237.515
VAT registered
Yes
Founded
09-09-1988
Latest accounts
2025
Employees
20 FTE
Region
Flanders
Establishments
2
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Lieven Bauwensstraat 6, 8200 Bruges
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
71209 Autres activités de contrôle et analyses techniques

Key figures of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 103 882-72 %€ 370 991-19 %€ 457 069
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 816 3100 %€ 816 3100 %€ 816 310
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 3 212 468-8 %€ 3 504 020-8 %€ 3 816 655
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 1 889 206-22 %€ 2 410 982-21 %€ 3 052 097
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
20-9 %22-3 %22.7

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Bruges.

CompanyTown
Global Water & Energy 8200 Brugge
Adviesbureau Saga 8200 Brugge
ECOMAB Milieuadviesbureau 8200 Brugge
BRAECKEVELT-LAFAUT 8200 Brugge
Schwung 8200 Brugge
Dr Ludo Vanopdenbosch 8200 Brugge
DONCK LIESBETH 8200 Brugge
Eurofins NSC Belgium 8200 Brugge
Looking for more information about EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM still active? Yes. The Crossroads Bank for Enterprises lists EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM as active.

What is the VAT number of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM? The VAT number of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is BE 0435.237.515.

When was EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM founded? EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM was founded on 09-09-1988.

What is the address of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM? The current registered office of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is Lieven Bauwensstraat 6, 8200 Bruges.

When did EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM last file annual accounts? The latest annual accounts of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM were filed on 17-07-2026.

Does EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM file its annual accounts on time? Yes. EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM have? EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM employs 20 full-time equivalents according to its most recent annual accounts.

Is EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM financially healthy? Addrly gives EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM profitable? The annual accounts of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM for 2025 show a profit of € 103 882.

What is the equity of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM? The equity of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM was € 816 310 at the close of the 2025 financial year.

Who are the directors of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM? The annual accounts of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM record 2 mandates. The names, roles and dates are visible with a free account.

Can EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM receive Peppol e-invoices? Yes. EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is registered on the Peppol network and can receive structured electronic invoices.

What does EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM do? The main activity of EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM is: Scientific research and development.

Sources

How Addrly builds and refreshes this data